Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 552, pseudogene (RN7SL552P) is a processed pseudogene originating from the 7SL RNA gene. The 7SL RNA is a non-coding RNA element that forms part of the signal recognition particle (SRP) complex, which is involved in targeting nascent proteins to the endoplasmic reticulum during translation[3][4][5]. RN7SL552P, like the majority of 7SL RNA-derived pseudogenes, is a truncated, nonfunctional copy that likely results from retrotransposition events. It does not encode a protein, is not expressed as a functional molecule, and is not regarded as a drug target, receptor, or biomarker. While some pseudogenes in the human genome can produce regulatory RNAs affecting gene expression as competing endogenous RNAs or siRNAs, most—including RN7SL552P—have no proven biological function or involvement in disease[2][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 552, pseudogene (RN7SL552P).